Telemedicine for medical abortion: a systematic review
- PMID: 30869829
- PMCID: PMC7496179
- DOI: 10.1111/1471-0528.15684
Telemedicine for medical abortion: a systematic review
Abstract
Background: Telemedicine is increasingly being used to access abortion services.
Objective: To assess the success rate, safety, and acceptability for women and providers of medical abortion using telemedicine.
Search strategy: We searched PubMed, EMBASE, ClinicalTrials.gov, and Web of Science up until 10 November 2017.
Study criteria: We selected studies where telemedicine was used for comprehensive medical abortion services, i.e. assessment/counselling, treatment, and follow up, reporting on success rate (continuing pregnancy, complete abortion, and surgical evacuation), safety (rate of blood transfusion and hospitalisation) or acceptability (satisfaction, dissatisfaction, and recommendation of the service).
Data collection and analysis: Quantitative outcomes were summarised as a range of median rates. Qualitative data were summarised in a narrative synthesis.
Main results: Rates relevant to success rate, safety, and acceptability outcomes for women ≤10+0 weeks' gestation (GW) ranged from 0 to 1.9% for continuing pregnancy, 93.8 to 96.4% for complete abortion, 0.9 to 19.3% for surgical evacuation, 0 to 0.7% for blood transfusion, 0.07 to 2.8% for hospitalisation, 64 to 100% for satisfaction, 0.2 to 2.3% for dissatisfaction, and 90 to 98% for recommendation of the service. Rates in studies also including women >10+0 GW ranged from 1.3 to 2.3% for continuing pregnancy, 8.5 to 20.9% for surgical evacuation, and 90 to 100% for satisfaction. Qualitative studies on acceptability showed no negative impacts for women or providers.
Conclusion: Based on a synthesis of mainly self-reported data, medical abortion through telemedicine seems to be highly acceptable to women and providers, success rate and safety outcomes are similar to those reported in literature for in-person abortion care, and surgical evacuation rates are higher.
Tweetable abstract: A systematic review of medical abortion through telemedicine shows outcome rates similar to in-person care.
Keywords: Medical abortion; telemedicine.
© 2019 World Health Organization; licensed by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists.
Comment in
-
Telemedicine for medical abortion - time to move towards broad implementation.BJOG. 2019 Aug;126(9):1103. doi: 10.1111/1471-0528.15802. Epub 2019 May 11. BJOG. 2019. PMID: 31009164 No abstract available.
Similar articles
-
Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study.BJOG. 2021 Aug;128(9):1464-1474. doi: 10.1111/1471-0528.16668. Epub 2021 Mar 24. BJOG. 2021. PMID: 33605016 Free PMC article.
-
Women's experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID-19) pandemic: a qualitative evaluation.BJOG. 2021 Oct;128(11):1752-1761. doi: 10.1111/1471-0528.16813. Epub 2021 Jul 27. BJOG. 2021. PMID: 34138505 Free PMC article.
-
Safety and acceptability of medical abortion through telemedicine after 9 weeks of gestation: a population-based cohort study.BJOG. 2019 Apr;126(5):609-618. doi: 10.1111/1471-0528.15553. Epub 2018 Dec 27. BJOG. 2019. PMID: 30456778
-
Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: a systematic review with meta-analyses.Am J Obstet Gynecol. 2020 Jun;222(6):551-563.e13. doi: 10.1016/j.ajog.2019.11.1244. Epub 2019 Nov 9. Am J Obstet Gynecol. 2020. PMID: 31715147
-
Self-administered versus provider-administered medical abortion.Cochrane Database Syst Rev. 2020 Mar 9;3(3):CD013181. doi: 10.1002/14651858.CD013181.pub2. Cochrane Database Syst Rev. 2020. PMID: 32150279 Free PMC article.
Cited by
-
Medical abortion is an essential service during the pandemic.Can Fam Physician. 2021 Apr;67(4):281-283. doi: 10.46747/cfp.6704281. Can Fam Physician. 2021. PMID: 33853918 Free PMC article. No abstract available.
-
Acceptance and use of mobile health technology in post-abortion care.BMC Health Serv Res. 2024 Sep 27;24(1):1130. doi: 10.1186/s12913-024-11633-5. BMC Health Serv Res. 2024. PMID: 39334105 Free PMC article.
-
Effectiveness and acceptability of home use of misoprostol for medical abortion up to 10 weeks of pregnancy.Acta Obstet Gynecol Scand. 2023 May;102(5):541-548. doi: 10.1111/aogs.14549. Epub 2023 Mar 18. Acta Obstet Gynecol Scand. 2023. PMID: 36933004 Free PMC article.
-
Easing of Regulatory Barriers to Telemedicine Abortion in Response to COVID-19.Front Glob Womens Health. 2021 Nov 24;2:705611. doi: 10.3389/fgwh.2021.705611. eCollection 2021. Front Glob Womens Health. 2021. PMID: 34901929 Free PMC article.
-
Expanding access to early medical abortion services in Ghana with telemedicine: findings from a pilot evaluation.Sex Reprod Health Matters. 2023 Dec;31(4):2250621. doi: 10.1080/26410397.2023.2250621. Epub 2023 Sep 20. Sex Reprod Health Matters. 2023. PMID: 37728548 Free PMC article.
References
-
- Doran F, Nancarrow S. Barriers and facilitators of access to first‐trimester abortion services for women in the developed world: a systematic review. J Fam Plann Reprod Health Care 2015;41:170–80. - PubMed
-
- Kassebaum NJ, Bertozzi‐Villa A, Coggeshall MS, Shackelford KA, Steiner C, Heuton KR, et al. Global, regional, and national levels and causes of maternal mortality during 1990‐2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England) 2014;384:980–1004. - PMC - PubMed
-
- Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet (London, England) 2006;367:1066–74. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical